Scinai Immunotherapeutics Ltd. - ADSs (BVXV)

CUSIP: 09073Q105

Q4 2018 13F Holders as of 31 Dec 2018

Holder snapshot 6 signals
Share change
+22,635
SEC-reported price per share
$4.77
Number of holders
10
Value change
+$105,507
Number of buys
1
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
592,878

Security key

09073Q105

Report period

Q4 2018

Institutions

10

Top holders

10

Ownership snapshot

Top reported holders of BVXV - Scinai Immunotherapeutics Ltd. - ADSs (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
IBEX INVESTORS LLC
Disclosed value leader
IBEX INVESTORS LLC
Comparable rows
11/11
Latest evidence
30 Sep 2018
13F Lead comparable stake: 61% Showing 1-6 of 11 holder rows.

Quick read

IBEX INVESTORS LLC leads the comparable SEC ownership view at 61%.

11 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens IBEX INVESTORS LLC's linked filing trail.
Comparable ownership Top 5
IBEX INVESTORS LLC 61%
BANK HAPOALIM BM 4.2%
Vantage Investment Advisors, LLC 4.2%
HighTower Advisors, LLC 2.8%
Psagot Value Holdings Ltd. 1.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 11 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
IBEX INVESTORS LLC
13F
Company
13F
61%
$2,010,000
359,000 shares
30 Sep 2018
BANK HAPOALIM BM
13F
Company
13F
4.2%
$141,000
25,176 shares
30 Sep 2018
Vantage Investment Advisors, LLC
13F
Company
13F
4.2%
$140,000
25,045 shares
30 Sep 2018
HighTower Advisors, LLC
13F
Company
13F
2.8%
$94,000
16,800 shares
30 Sep 2018
Psagot Value Holdings Ltd.
13F
Company
13F
1.8%
$61,000
10,877 shares
30 Sep 2018
UBS Group AG
13F
Company
13F
0.77%
$25,000
4,552 shares
30 Sep 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
10
Shares
446,374
Rows available
10
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders
11
Q4 2018 holders
10
Holder diff
-1
Investor Q3 2018 Shares Q4 2018 Shares Share Diff Share Chg % Q3 2018 value Q4 2018 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .